RPE was differentiated from hiPSCs, and
CLDN19 was knocked down using siRNA. As controls, RPE was mock transfected or transfected with siRNAs to
PPIB (cyclophilin B) and
CLDN4, a claudin not expressed by RPE.
39 Consistent with our earlier studies,
17,18,39 the siRNA directed against
CLDN19 reduced the expression of claudin-19 and reduced the TER (
Fig. 1). The decreases in TER and expression of claudin-19 required a week after the second treatment with siRNA, suggesting a long half-life for claudin-19 as reported for claudin-2.
40 The TER began to increase after 3 weeks, demonstrating the viability of the cultures. The slow recovery is consistent with a variety of RPE culture models, including hiPSC–RPE. After replating RPE, adherens junctions reassemble quickly, but reassembly of tight junctions requires 4 to 6 weeks.
41 Accordingly, TER was used to assess the effectiveness of the knockdown. For cultures that were effectively knocked down, the 1-week time point was used to initiate analysis of each siRNA experiment.
Figure 1B confirmed that the expression of claudin-19 was low for the duration of the experiments described below. Despite the decreased expression of claudin-19, zonula occludens-1 (ZO-1) and filamentous actin remained in circumferential bands in the position of the apical junctional complex (
Fig. 2).
These data indicated that tight junctions were disrupted, but the adherens junction portion of the apical junctional complex remained intact. When the apical junctional complex is completely disassociated, reassociation of the complex requires activation (phosphorylation) of AMPK.
20–23 AMPK is an energy sensor that can activate, or inactivate, anabolic and catabolic pathways depending on the AMP/ATP ratio,
23,42,43 but its effects on the reassembly of tight junctions are independent of energy levels. In the current study, reducing the amount of claudin-19 alone was sufficient to increase the pAMPK/AMPK ratio relative to the
CLDN4 KD control (
Fig. 3). Activated AMPK can inhibit anabolic pathways and stimulate catabolic pathways, including autophagy. In the knockdown experiments, pAMPK had little effect on Unc-51-like kinase 1 (ULK1), an upstream kinase in the autophagy pathway, and phosphorylation decreased for Raptor-1, an indirect activator of ULK1.
44,45